tiprankstipranks
Trending News
More News >
Globestar Therapeutics Corporation (GSTC)
:GSTC
US Market

GlobeStar Therapeutics (GSTC) Income Statement

Compare
16 Followers

GlobeStar Therapeutics Income Statement

Last quarter (Q3 2024), GlobeStar Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, GlobeStar Therapeutics's net income was $-197.66K. See GlobeStar Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 77.00$ 425.00
Gross Profit
$ 0.00$ 0.00$ -2.41K$ -37.60K$ 271.00
Operating Expenses
$ 1.86M$ 1.27M$ 9.09M$ 266.07K$ 316.14K
Depreciation and Amortization
$ 1.86M$ 1.27K$ 1.27K$ 1.33K$ 472.00
EBITDA
$ 6.72K$ -1.26M$ -9.09M$ -302.34K$ -314.23K
Operating Income
$ -1.86M$ -1.27M$ -9.09M$ -303.67K$ -315.87K
Other Income/Expenses
$ -84.88K$ -222.75K$ -707.40K$ -238.06K$ -359.20K
Pretax Income
$ -1.95M$ -1.49M$ -9.80M$ -541.73K$ -675.07K
Net Income
$ -1.95M$ -1.64M$ -9.67M$ -779.79K$ -1.04M
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ -0.02$ 0.00$ -0.01
Diluted EPS
$ 0.00$ 0.00$ -0.02$ 0.00$ -0.01
Weighted Average Shares Outstanding
827.32M 628.54M 482.09M 298.09M 104.78M
Weighted Average Shares Outstanding (Diluted)
827.32M 628.54M 482.09M 298.09M 104.78M
Currency in USD

GlobeStar Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis